HLK Biotech Semi Variance
| AMHD Stock | | | USD 0.0002 0.00 0.00% |
This technical indicator view for Semi Variance organizes signals for HLK Biotech Holding and comparable instruments. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. HLK Biotech has a market cap of 462.46 K.
Trending Equities can help frame allocation decisions. This reflects a position in HLK Biotech Holding within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in rate.
HLK Biotech Holding has current Semi Variance of 0. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 0 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
HLK Biotech Semi Variance Peers Comparison
HLK Semi Variance Relative To Other Indicators
HLK Biotech Holding is rated
below average for semi variance relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers .
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.